Basket trials: From tumour gnostic to tumour agnostic drug development

Volume: 90, Pages: 102082 - 102082
Published: Nov 1, 2020
Abstract
Molecular profiling provides the insight that specific genetic alterations can be detected across a wide range of different histologically characterised tumour types. Thus, the basic concept of basket trials (BTs) to target those genetic alterations with the same anti-tumour agents independent of the underlying tumour type was tumour agnostic. BTs can be divided into tumour gnostic, tumour semi-gnostic, and tumour agnostic trials which cover BTs...
Paper Details
Title
Basket trials: From tumour gnostic to tumour agnostic drug development
Published Date
Nov 1, 2020
Volume
90
Pages
102082 - 102082
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.